MODERATE PLAQUE PSORIASIS
Clinical trials for MODERATE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New psoriasis drug study aims to clear skin and restore quality of life
Disease control OngoingThis study observes how well the approved medication risankizumab works for people recently diagnosed with moderate plaque psoriasis in real-world Greek clinics. About 250 participants who haven't tried advanced treatments will be followed for two years while taking risankizumab …
Matched conditions: MODERATE PLAQUE PSORIASIS
Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
Head-to-Head: which psoriasis treatment works better?
Disease control OngoingThis study compares two already-approved medicines for moderate plaque psoriasis. It tests if an injection given every 12 weeks (risankizumab) works better than a daily pill (deucravacitinib) at clearing skin. About 336 adults who have not tried biologic treatments will participa…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC